| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.0062 | 1 |